TransMedics, Inc.
$4.1M 495 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Lundbeck LLC
Lundbeck LLC reported $4,073,619.60 across General Payments, Research, and Ownership to 111,317 physicians and teaching hospitals across 111,317 transactions.
- $4.1M Top quartile payer
- All-tracks total
- 111,317 Top 10% volume
- Transactions
- 111,317 Top 10% reach
- Recipients
- +$135.6K
- General Payments vs PY2023
Lundbeck LLC reported $4,073,619.60 across all CMS Open Payments tracks (General + Research + Ownership) to 111,317 physicians and teaching hospitals in Program Year 2024 - ranking #304 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $4,073,619.60, averaging $36.59 per recipient.
How Lundbeck LLC's $4.1M all-tracks total breaks down
Lundbeck LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
B
81/100
Total payments
F
48/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lundbeck-llc Lundbeck LLC
$4.1M · #304/1,925 · 0.0% industry · PY2024
- TOT $4.1M
- RANK #304
- SHARE 0.0%
- TXN 111,317
- RCP 111,317
- CAT 6
- GEN $4.1M
- ΔGEN +$135.6K
- TOP1 8.4%
- PY 2024
Volume peers
Nearest volume peer: TransMedics, Inc. ($4.1M)
Lundbeck LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Lundbeck LLC's CMS-reported General Payments increased by $135.6K (+3.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LUNDBECK LLCPY2023: LUNDBECK LLCPY2024: Lundbeck LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,938,016.29
- PY2024
- $4,073,619.60
What the Data Shows for Lundbeck LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Lundbeck LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
"Food and Beverage" leads the 6-category general-payment breakdown below at $2.2M (55.1% of General Payments, 109,964 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Food and Beverage" leads Lundbeck LLC's 6-category general-payment breakdown at $2.2M, 55.1% of the reported total.
Lundbeck LLC reports 6 general-payment categories - the top three are Food and Beverage (55.1%), Honoraria (18.7%), and Royalty or License (16.8%). The remaining 3 categories make up 9.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Lundbeck LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $2.2M | 109,964 | 55.1% |
| Honoraria | $763.8K | 336 | 18.7% |
| Royalty or License | $684.8K | 4 | 16.8% |
| Consulting Fee | $304.8K | 486 | 7.5% |
| Travel and Lodging | $74.9K | 463 | 1.8% |
| Education | $327.99 | 64 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $885,452.69 (21.7%) of $4,073,619.60 in this company's General Payments records across 32,414 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lundbeck LLC
The five named recipients with the highest reported General Payments from this company
- 1
Roy Elterman
$342,375.21 across 2 reported transactions
- 2
William Shields
$342,375.21 across 2 reported transactions
- 3
Wade Cooper
$73,884.42 across 91 reported transactions
- 4
Chaouki Khoury
$70,228.74 across 81 reported transactions
- 5
Stephen Landy
$56,589.11 across 68 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lundbeck LLC ranks #304 of 1,925 by total payments (top 16% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,616 of 1,838 by HHI (bottom 12% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Radius Health, Inc. : $792.8K total payments, HHI 162
- Kuros Biosciences USA, Inc : $711.3K total payments, HHI 162
- Merz Pharmaceuticals, LLC : $919.5K total payments, HHI 162
- Vanda Pharmaceuticals Inc. : $4.6M total payments, HHI 160
- CeQur Corporation : $420.1K total payments, HHI 160
- Kiniksa Pharmaceuticals International, plc : $1.7M total payments, HHI 159
- Lundbeck LLC (this company) : $4.1M total payments, HHI 159
- Foundation Fusion Solutions, LLC : $106.1K total payments, HHI 157
- Heartflow, Inc. : $1.7M total payments, HHI 157
- Globus Medical, Inc. : $27.0M total payments, HHI 156
- Saxum Surgical, Inc. : $48.5K total payments, HHI 156
- Legacy Ortho LLC : $39.6K total payments, HHI 155
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lundbeck LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lundbeck LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lundbeck LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Intellijoint Surgical Inc.
$4.0M 47 recipients
Compare payment profiles
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4.0M 80,252 recipients
Compare payment profiles
Masimo Corporation
$4.0M 2,386 recipients
Compare payment profiles
Impulse Dynamics (USA) Inc.
$4.0M 6,539 recipients
Compare payment profiles
Responsive Arthroscopy Inc
$4.1M 116 recipients
Compare payment profiles
Put this to use
Lundbeck LLC ranks #304 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See where Lundbeck LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Lundbeck LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.